Teva Narrows FY19 Guidance: Sales From $17B-$17.4B To $17.2B-$17.4B vs $17.18B Estimate, EPS From $2.20-$2.50 To $2.30-$2.50 vs $2.38 Est.

Benzinga · 11/07/2019 12:04